N4 Pharma Plc Announces Holding(s) in Company
Why we think this is neutral
This RNS announcement is a notification of a change in major shareholding, which does not fall into any of the mandatory news categories that would require a more detailed analysis. The information provided is factual and does not indicate any significant positive or negative developments for the company.
Key Points
- Tracarta Limited now holds 18.02% of the voting rights in N4 Pharma Plc
- The shares have been dematerialised into Fiske Nominees Limited
Summary
The healthcare company has announced a change in major shareholding, with Tracarta Limited now holding 18.02% of the voting rights.
N4 Pharma Plc, a specialist pharmaceutical company, has announced a change in major shareholding. Tracarta Limited now holds 18.02% of the voting rights in the company.
DIRECTOR DEALINGS